Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Control of Human PLP1 Expression Through Transcriptional Regulatory Elements and Alternatively Spliced Exons in Intron 1.
Commentary on 'Disability outcome measures in multiple sclerosis clinical trials'
Multiple Sclerosis and the Iranian Revolution: Reply to the Comment by Magzhi et al..
Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors.
IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development.
Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis.
T-bet Expression by Foxp3(+) T Regulatory Cells is Not Essential for Their Suppressive Function in CNS Autoimmune Disease or Colitis.
Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 - 2014).
Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions.
Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Lack of association between CD226 genetic variants and inflammatory demyelinating diseases in Korean population.
Clinical and Radiological Characteristics in Multiple Sclerosis Patients with Large Cavitary Lesions.
Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis.
Novel Therapeutic Targets and Drug Candidates for Modifying Disease Progression in Adrenoleukodystrophy.
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
The active form of vitamin D transcriptionally represses the Smad7 signaling and activates ERK to inhibit the differentiation of a inflammatory T helper cell subset and suppress experimental autoimmune encephalomyelitis.
The best clinical paper on multiple sclerosis in 2012.
Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect.
Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis.
Targeting molecules to medicine with mTOR, autophagy, and neurodegenerative disorders.
Protective Autoimmunity: A Unifying Model for the Immune Network Involved in CNS Repair.
Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.
Quantitative MRI demonstrates abnormality of the fornix and cingulum in multiple sclerosis.
Redefining Self: Patients' Decision Making About Treatment for Multiple Sclerosis.
Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β

Pages